Sibel Health
Wireless clinical monitoring company building soft wearable sensors for neonates and other high-acuity patients across hospital and home settings.
What They Do
Sibel Health builds the ANNE platform, a wireless wearable monitoring system that captures multiparameter vital signs through soft skin-mounted sensors, mobile software, and cloud analytics. In neonatal care, its clearest wedge is reducing the cable burden that can interfere with kangaroo care, sleep, and nurse workflow in the NICU while still supporting continuous heart rate, respiratory rate, SpO2, and temperature monitoring. The company also sells into broader hospital and research use cases, including pharmaceutical data collection, so the business model looks more like enterprise device-plus-software sales than reimbursed virtual care. I did not find public evidence of a payer-driven revenue mix; public materials instead emphasize provider, research, and strategic-partner deployments.
Competitive Position
Sibel competes with incumbent wired NICU monitoring vendors such as Masimo, Philips, GE HealthCare, and Drager, as well as newer wireless-monitoring companies like neopenda. Its differentiation is the combination of neonatal-specific wearable design, FDA-cleared clinical monitoring, and a platform strategy that spans NICU, general acute care, home monitoring, and research use cases. That breadth could become a distribution advantage, but it also means Sibel is not a pure-play neonatal company in the way some smaller competitors are.
Funding Rounds
Q2 2026: Non-dilutive grant; tied to ANNE Maternal FDA clearance and AI features development